Sponsor:  National Institutes of Health (NIH)

Sponsor Program Solicitation: RFA-DA-14-004
Funding Amount: $3 Million
Duration: Up to 5 years

Status of this Limited Submission Opportunity



NU Pre-Proposal Deadline: 05/15/2013
Sponsor Deadline: 08/15/2013
Letter of Intent Deadline: 07/15/2013

Eligibility and Nomination Requirements

Northeastern may only submit one proposal. This limited submission opportunity is still open. If you are interested in submitting, please contact Karen Drew (x4824) immediately.

Funding Areas

This FOA solicits Specialized Center Cooperative Agreement (U54) applications to provide support for Medications Development Centers of Excellence (MDCE) with emphasis on clinical research directed towards the identification, evaluation, and development of safe and effective medications and biologics for treatment of substance use disorders (SUDs). Research may focus on both currently approved or novel, investigational products. Centers may have a translational component to reinforce rationale of medications for testing.